Current Law Journal Content
Washington & Lee Law School
  Current Law Journal Content
                  an index to legal periodicals
 


  Biotechnology Law Report
  Volume 23, Number 5, October 2004
  homepage                   other issues
 

  • Foreword
  • A Call for Debate
        Robert A. Bohrer
        p.541                                                                                      +cite        

  • Perspective
  • Longevity Research and Bioethics
        Robert A. Bohrer
        p.542-547                                                                              +cite        

  • Papers
  • Admissibility of a Disclaimer in Patent Claims: The Standard as Set by the EPO Enlarged Board of Appeal Decision G01/03
        Franz-Josef Zimmer, Svenja Sethmann
        p.548-555                                                                              +cite        
  • Patenting of "Higher Life Forms" in Canada
        Adrian Zahl
        p.556-560                                                                              +cite        

  • Analyses of Recent Decisions
  • Another Contribution to the Claim Construction Debate
        Harold C. Wegner
        p.561-562                                                                              +cite        
  • Who Is an Inventor?
        Harold C. Wegner, Gerry J. Elman
        p.563                                                                                      +cite        

  • Regulatory Affairs—Pharmaceutical
  • FDA Revises Procedures for Response to Unapprovable NDAs/ New Office for Cancer Drugs at FDA/ Several Countries Take Action on Human Cloning
        p.564                                                                                      +cite    
  • Clinical Trials
        p.567                                                                                      +cite    

  • Regulatory Affairs—Agricultural and Environmental
  • Pew Initiative Analyzes Challenges of Future Technology
        p.568-570                                                                              +cite    

  • Patents
  • ESTs Fail to Make the Grade, Again/ CAFC Upholds Rejection of DNA Claims Based on Partial Protein Sequence/ Changes in Acceptable Organisms, Fees at ATCC
        p.571-574                                                                              +cite    

  • Patent Litigation
  • CAFC Refuses en Banc Review of Rochester/ CAFC to Hear Phillips Case en Banc/ CAFC Puzzles over Meaning of "Intracellular"/ Novo Nordisk's hGH Patent Falls/ "Clear and Convincing" Evidence Is Required to Add an Inventor/ The Meaning of "Consisting of," the Importance of Spatulas/ Water, Water Anywhere?/ Beckman Wins Appeal in Infringement Suit/ Filing an ANDA Is Not Willful Infringement
        p.575-594                                                                              +cite    

  • Electronic Biotechnology
  • Information on Licensing Strategies from Wood MacKenzie
        p.595                                                                                      +cite    

  • Professional Practice
  • Arizona State to Offer Master's Degree in Biotechnology and Genomics Law/ Bio-Rad Sues Townsend and Townsend over Patent Litigation
        p.596                                                                                      +cite    

  • Bibliography
  • Protecting Treatment-Related IP in Japan/ Licensing of the Oncomouse/ Cost of European Patents
        p.597                                                                                      +cite    
  • On the Move
        p.598-599                                                                              +cite    

  • Texts
  • United States Patent and Trademark Office: Before The Board of Patent Appeals and Interferences: Ex parte Dane K. Fisher and Raghunath v. Lalgudi; Appeal No. 2002-2046
        p.600-610                                                                              +cite    
  • United States Court of Appeals for the Federal Circuit: In re David Wallach, Hartmut Engelmann, Dan Aderka, Daniela Novick, and Menachem Rubinstein (Serial No. 08/485,129)(03-1327)
        p.611-615                                                                              +cite    
  • United States Court of Appeals for the Federal Circuit: Order on Petition for Rehearing en Banc: University of Rochester v. G.D. Searle & Co., Inc., Monsanto Company, Pharmacia Corporation, and Pfizer Inc. (03-1304)
        p.616-638                                                                              +cite    
  • United States Court of Appeals for the Federal Circuit: Milton D. Goldenberg and Immunomedics, Inc., v. Cytogen, Inc., and C.R. Bard, Inc. (03-1409)
        p.639-648                                                                              +cite    
  • In the United States District Court for the District of Delaware: Novo Nordisk Pharmaceuticals, Inc., and Novo Nordisk A/S v. Bio-Technology General Corp. and Teva Pharmaceuticals USA, Inc. (Civ. No. 02-332-SLR)
        p.649-677                                                                              +cite    
  • United States Court of Appeals for the Federal Circuit: Eli Lilly and Company v. Aradigm Corporation (03-1336, -1337)
        p.678-691                                                                              +cite    
  • United States Court of Appeals for the Federal Circuit: SmithKline Beecham Corporation and Beecham Group, P.L.C., v. Apotex Corp., Apotex, Inc., and TorPharm, Inc. (03-1285, -1313)
        p.692-713                                                                              +cite    
  • United States Court of Appeals for the Federal Circuit: Glaxo Group Limited and SmithKline Beecham Corp. v. Apotex, Inc. (03-1575)
        p.714-722                                                                              +cite    
  • Coming Events
        p.723-725                                                                              +cite